COVID-19 vaccine Archives
VUMC-led study finds Moderna COVID vaccine safe and effective for children
May. 12, 2022— by Bill Snyder Moderna’s COVID-19 vaccine is safe and generates robust immune responses in children ages 6 to 11 years, a national clinical trial co-led by Vanderbilt University Medical Center vaccine expert C. Buddy Creech, MD, MPH, has found. The two-dose vaccine (given approximately one month apart) led to antibody responses in more than...
COVID-associated bleeding risk
May. 5, 2022—While case reports have noted acquired hemophilia after COVID-19 infection or vaccination, a new study finds no increased risk.
VUMC offers second booster to eligible individuals
Apr. 25, 2022—Based on updated CDC COVID-19 booster guidelines and VUMC’s review of the evidence, VUMC will offer a second booster of the Pfizer COVID-19 vaccine to eligible individuals, ages 50 and over, who received either the Pfizer or Moderna vaccines. Others who are eligible for a second booster include those who received the Johnson & Johnson...
Additional COVID vaccine helps protect transplant patients
Apr. 13, 2022—Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows.
Volunteering for vaccine research a family affair
Apr. 13, 2022—by Kristin Smart The Disney dream was deferred. Jennifer Andrews, her husband Chris Murdock, and their 6-year-old daughter Ella were all packed for a trip to Disney World in early March 2020, when they joined much of the world in having their plans upended by the COVID-19 pandemic. “We were supposed to leave on March...
Study explores parents’ reluctance to flu, COVID vaccines for children
Apr. 7, 2022—Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children.
Teen shares his battle with MIS-C following COVID-19 infection
Mar. 7, 2022—Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.
COVID-19: two years of challenges, lessons, victories
Mar. 3, 2022—Two years ago this week, the cataclysmic coronavirus known as SARS-CoV-2 arrived in Middle Tennessee.
MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis
Feb. 24, 2022—A Vanderbiltl study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C).
Vanderbilt and CDC research shows third vaccine dose key to preventing omicron hospitalization
Feb. 9, 2022—Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.
Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines
Jan. 24, 2022—Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children.
Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms
Dec. 2, 2021— by Bill Snyder The global biopharmaceutical company AstraZeneca announced more good news about its long-acting combination of two monoclonal antibodies against COVID-19 that were discovered at Vanderbilt University Medical Center. In a prevention trial, one prophylactic, intramuscular injection of the antibody combination, called AZD7442, reduced the risk of symptoms occurring after exposure to the...
